Test Price
15,000 AED✅ Home Collection Available
Sarcoma Gene Panel in UAE | 15,000 AED | DNA Labs UAE
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity – ISO 9001:2015 Accredited NGS analysis (Cert: INT/EGQ/2509DA/3139).
- Secure Medical Courier Solid Tissue Specimen Retrieval – Temperature-controlled cold-chain transport for FFPE blocks, biopsy slides, and surgical pathology cuts.
- Clinical Guidance Included – Telephonic Post-Test Interpretation by DHA-Certified specialists.
- Insurance Direct Billing – WhatsApp verification: +971 54 548 8731.
Test Overview & Methodology
The Sarcoma Gene Panel is a comprehensive genetic test that analyses tumour tissue for clinically actionable mutations across a broad set of sarcoma-related genes. Clinically validated at DNA Labs UAE under DHA regulatory standards, this panel enables precise risk assessment, targeted therapy selection, and family counselling.
| Feature | Our NGS Sarcoma Panel | Closest Alternative (Single Gene Tests) |
|---|---|---|
| Methodology | NGS (Next Generation Sequencing) | Sanger / FISH – limited gene coverage |
| Precision | 99.9% diagnostic sensitivity | ~95% – single variant focus, may miss co‑mutations |
| Turnaround Time | 4 – 6 weeks | Varies; sequential testing can exceed 8 weeks |
| Specimen | FFPE tumour tissue blocks, biopsy slides, or surgical pathology cuts | Often blood; tumour tissue required for comprehensive profiling |
Physician Insight & Safety Protocols
"A genetic diagnosis illuminates the molecular architecture of sarcoma, guiding precision therapy and hereditary risk assessment. Comprehensive panel testing, when integrated with histopathological and clinical data, provides the clarity needed for informed clinical decisions. At DNA Labs UAE, our NGS platform delivers actionable insights with rigorous quality assurance."
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
Do not discontinue or adjust prescribed medications based on test results without consulting your doctor.
Exclusion Criteria & ER Red Flags
- Unsuitable for emergency diagnosis or intra‑operative decision making.
- Test not recommended as a standalone screening tool for asymptomatic individuals.
- Pregnancy and paediatric cases require specific DHA‑approved consent protocols per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Seek emergency care immediately if you experience: rapid growth of a mass, sudden severe pain at tumour site, or signs of haemorrhage – these may indicate aggressive disease requiring urgent oncology consultation.
Patient FAQ & Clinical Guidance
1. What is the Sarcoma Gene Panel and what conditions does it assess?
The Sarcoma Gene Panel detects clinically actionable mutations in soft tissue and bone‑related cancers, guiding targeted therapy, prognosis, and familial risk stratification with 99.9% sensitivity. The analysis covers a comprehensive set of genes known to drive sarcoma pathogenesis, enabling a precise molecular diagnosis.
2. Do I need a prescription to take this test?
A registered physician’s prescription is required, except for patients scheduled for surgery, pregnant women, or individuals planning international travel. Your referring clinician must complete a DHA-compliant test requisition form before sample collection can proceed.
3. How reliable are the results and how will I receive them?
Results are 99.9% accurate using ISO‑certified NGS technology, delivered through a secure digital report and a complimentary telephonic consultation with a clinical specialist. The final report includes variant interpretations, therapeutic implications, and hereditary risk indicators.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient genetic data is encrypted, access‑controlled, and processed exclusively within UAE‑based secure servers. DNA Labs UAE adheres to DHA and MOHAP standards for laboratory accreditation and clinical governance. Clinical safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Sarcoma Gene Panel |
| Price (AED) | 15,000 |
| Turnaround Time | 4–6 weeks |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) tumour tissue blocks, biopsy slides, or surgical pathology cuts |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | C49.9 |
| LOINC Code | 104200-6 |
| DHA Facility License & Lab Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians